NZX assessing further complaint over Grant Samuel's Abano report

The NZX has confirmed it is assessing a second complaint lodged in relation to a Grant Samuel valuation report commissioned by medical investor Abano Healthcare [NZX: ABA].

The issue is one of many that rebel shareholders Peter Hutson and James Reeves are pushing in their bid to oust

Want to read more? It's easy.

Choose your subscription

Already have an account? Login

Smartphone Only Subscription

NZ$29.95 / monthly

Monthly Premium Online Subscription

NZ$49.95 / monthly

Smartphone Only Annual Subscription

NZ$299.00 / yearly

Yearly Premium Online Subscription

NZ$499.00 / yearly

Premium Group Membership 10 Users

NZ$385+GST / monthly

$38.5 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$660+GST / monthly

$33 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1375+GST / monthly

$27.5 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$2100+GST / monthly

$21 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$999.00 / yearly

Individual

Group membership

NBR Marketplace

Student

Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).

View terms and conditions.

Duncan Bridgeman
Fri, 06 Jun 2014

Categories

Analysis

Featured